We detected mutations in TP53 pathway genes such as MDM4 and ATM, especially TP53, which acts as a vital player in the cancer arena, was the most frequently mutated genes in B-cell lymphomas in our cohort (20%, 16/79). Here, TP53 is linked to B-cell non-Hodgkin lymphoma.